EligibleTrials

Hydrus® Microstent New Enrollment Post-Approval Study

Recruiting · NCT04553523 · Interventional (participants receive a specific treatment) · Lead sponsor: Alcon Research

View the official record on ClinicalTrials.gov →
Hypertension

Interventions studied

Cataract surgeryHydrus MicrostentMonofocal IOL

What this trial is about

The purpose of this post-approval study is to evaluate the rate of Hydrus Microstent malposition and associated clinical sequelae occurring within 24 months post-operation. Qualified subjects will undergo uncomplicated cataract surgery with placement of a monofocal intraocular lens (IOL), followed by implantation of the Hydrus Microstent.

Who can take part

Age range
45 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

22 locations listed across 15 US states.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.